Can mango flavored pills get rid of worms?

A new pill being developed to treat intestinal worms has shown promising results in trials and could help eradicate the parasitic infection that affects about 1.5 billion people worldwide, researchers say.

Mango-flavored pills are a combination of two existing anti-parasitic drugs that, when used together, are more effective in getting rid of worms.

These worms are picked up by contact with food or water that has been contaminated with soil contaminated with worm eggs, and infections cause severe gastrointestinal symptoms, malnutrition, and anemia.

Researchers say the pills could help overcome any future drug resistance problems and better manage the disease on a large scale.

The parasites, also known as soil-transmitted helminths (STH), include hookworms and hookworms and are endemic in many developing countries where hygiene is poor.

Many of the victims are children, and there is no preventive treatment other than improved sanitation.

According to a study called “LIVE”published in the Lancet, this new pill could help the most affected countries meet the goals set in the World Health Organization eliminate diseases.

It was taken as a fixed dose of one or three pills for consecutive days.

Researchers from eight European and African institutes say it would be a simple way to cure large numbers of people in mass treatment programs.

“It’s easy to use because it’s a single pill,” says project leader Professor Jose Muñoz.

“Furthermore, we hope that combining two drugs with different mechanisms of action will reduce the risk of parasites becoming drug-resistant,” says Professor Muñoz.

After infection, the parasites take root in the human digestive tract.

While the drug albendazole is good at treating some types of THG, it appears to be less effective at treating some others.

In clinical trials involving 1,001 children aged 5 to 18 in Ethiopia, Kenya and Mozambique, it was found to be more effective for more types of infections when combined with the drug ivermectin.

However, the researchers said the results were inconclusive about how well it treated the worm.

Professor Hani Elsheikha, a parasitology expert at the University of Nottingham, said the pills could be a “significant improvement over other treatments” and could be used against multiple parasites.

“There are some problems with existing drugs … so this could be an important, important addition.”

However, he said that while the study was “promising”, it had “some gaps”.

“We don’t know if the results will be the same for adults, older people, younger children, people in other parts of the world.”

Test results have been submitted to regulators in Europe and Africa, and decisions are expected in early 2025.

Participants are now being recruited for the next trial of over 20,000 people in Kenya and Ghana.

Dr. Stella Kefa, a research fellow at the Kenya Institute of Medical Research who worked on the study, said the pills had “great potential to improve the health of affected communities” but “work needed to be done” to make the treatment widely available.